Literature DB >> 25600930

Subcutaneous abscess due to the basidiomycete Phellinus mori in a patient with chronic granulomatous disease.

T Shigemura1, Y Nakazawa, Y Amano, A Sudo, M Watanabe, M Kobayashi, N Kobayashi, K Koike, K Agematsu, K Nishimura.   

Abstract

Chronic granulomatous disease (CGD), a primary immunodeficiency caused by impaired phagocyte killing of intracellular pathogens, is characterized by recurrent, life-threatening, bacterial and fungal infections. As a result of improvements in microbiologic culture and identification techniques, a number of unique filamentous fungi have been reported as significant pathogens in patients with CGD. We report a case of subcutaneous basidiomycete Phellinus mori infection in a patient with CGD. To the best of our knowledge, this is the first reported case of human infection by this fungus. The causative fungus was identified on the basis of its morphological characteristics and nucleotide sequence on the internal transcribed spacer region of the ribosomal RNA gene. This is the fifth case report of filamentous basidiomycetes infecting a patient with CGD; all of these cases have been caused by Phellinus species. We highlight the importance of recognizing filamentous basidiomycetes Phellinus species as possible agents of non-Aspergillus fungal infections in patients with CGD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25600930     DOI: 10.1007/s15010-015-0724-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  Discovering potential pathogens among fungi identified as nonsporulating molds.

Authors:  June I Pounder; Keith E Simmon; Claudia A Barton; Sheri L Hohmann; Mary E Brandt; Cathy A Petti
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

Review 2.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

3.  Phellinus tropicalis abscesses in a patient with chronic granulomatous disease.

Authors:  Manish Ramesh; Elena Resnick; Yiqun Hui; Paul J Maglione; Harshna Mehta; Jacob Kattan; Nicole M Bouvier; Vincent LaBombardi; Tanya R Victor; Sudha Chaturvedi; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2013-12-06       Impact factor: 8.317

4.  Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France.

Authors:  Julien Beauté; Gaëlle Obenga; Loïc Le Mignot; Nizar Mahlaoui; Marie-Elisabeth Bougnoux; Richard Mouy; Marie-Anne Gougerot-Pocidalo; Vincent Barlogis; Felipe Suarez; Fanny Lanternier; Olivier Hermine; Marc Lecuit; Stéphane Blanche; Alain Fischer; Olivier Lortholary
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

5.  Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract.

Authors:  Anuradha Chowdhary; Kshitij Agarwal; Shallu Kathuria; Pradeep Kumar Singh; P Roy; S N Gaur; G S de Hoog; Jacques F Meis
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

6.  Diagnostic difficulties caused by a nonclamped Schizophyllum commune isolate in a case of fungus ball of the lung.

Authors:  L Sigler; L M de la Maza; G Tan; K N Egger; R K Sherburne
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

7.  Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.

Authors:  Baldassarre Martire; Roberto Rondelli; Annarosa Soresina; Claudio Pignata; Teresa Broccoletti; Andrea Finocchi; Paolo Rossi; Marco Gattorno; Marco Rabusin; Chiara Azzari; Rosa M Dellepiane; Maria C Pietrogrande; Antonino Trizzino; Paolo Di Bartolomeo; Silvana Martino; Luigi Carpino; Fausto Cossu; Franco Locatelli; Rita Maccario; Paolo Pierani; Maria C Putti; Achille Stabile; Luigi D Notarangelo; Alberto G Ugazio; Alessandro Plebani; Domenico De Mattia
Journal:  Clin Immunol       Date:  2007-11-26       Impact factor: 3.969

8.  Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.

Authors:  Carla M Davis; Lenora M Noroski; Megan K Dishop; Deanna A Sutton; Richard M Braverman; Mary E Paul; Howard M Rosenblatt
Journal:  Pediatr Infect Dis J       Date:  2007-07       Impact factor: 2.129

9.  Paravertebral mushroom: identification of a novel species of Phellinus as a human pathogen in chronic granulomatous disease.

Authors:  Suk See De Ravin; Mark Parta; Deanna A Sutton; Brian L Wickes; Elizabeth H Thompson; Nathan P Wiederhold; Karen K Nakasone; Meghna Alimchandani; Amy OConnell; Luigi Notarangelo; Elizabeth Kang; Harry L Malech; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

10.  Chemical characterization and structure of exopolysaccharides from submerged culture of new medicinal mushroom from China, Phellinus mori (higher Basidiomycetes).

Authors:  Chunlei Cao; Feng Peng; Bao-Kai Cui
Journal:  Int J Med Mushrooms       Date:  2013       Impact factor: 1.921

View more
  3 in total

Review 1.  Infectious Complications in Patients With Chronic Granulomatous Disease.

Authors:  Nicholas Bennett; Paul J Maglione; Benjamin L Wright; Christa Zerbe
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

2.  Inonotosis in Patient with Hematologic Malignancy.

Authors:  Ana Fernández-Cruz; Mi Kwon; Jesús Guinea; Pilar Escribano; María Del Carmen Martínez Jiménez; Ana Pulido; Verónica Parra; David Serrano; Jorge Gayoso; José Luis Díez Martín; Emilio Bouza
Journal:  Emerg Infect Dis       Date:  2018-01       Impact factor: 6.883

3.  Systemic Inonotus sp. Infection in a dog.

Authors:  Yu Furusawa; Masashi Takahashi; Tomoko Iwanaga; Akira Yabuki; Rui Kano; Hitoshi Hatai; Wako Sueno; Yasuyuki Endo; Yasuyuki Momoi
Journal:  J Vet Med Sci       Date:  2020-05-04       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.